| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. | CHIEF COMMERCIAL OFFICER | Common Stock | 73.1K | $180K | $2.46 | Aug 27, 2024 | Direct |
| Verrica Pharmaceuticals Inc. | CHIEF COMMERCIAL OFFICER | Employee Stock Option (right to buy) | 80K | Mar 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Aug 26, 2024 | 2 | -$87.8K | 4 | Aug 28, 2024 | CHIEF COMMERCIAL OFFICER |
| VRCA | Verrica Pharmaceuticals Inc. | Jul 22, 2024 | 2 | -$181K | 4 | Jul 23, 2024 | CHIEF COMMERCIAL OFFICER |
| VRCA | Verrica Pharmaceuticals Inc. | Mar 15, 2024 | 2 | $0 | 4 | Mar 19, 2024 | CHIEF COMMERCIAL OFFICER |
| VRCA | Verrica Pharmaceuticals Inc. | Nov 14, 2023 | 2 | -$96.7K | 4 | Nov 16, 2023 | Chief Commercial Officer |
| VRCA | Verrica Pharmaceuticals Inc. | Aug 24, 2023 | 1 | $0 | 4 | Aug 28, 2023 | Chief Commercial Officer |
| VRCA | Verrica Pharmaceuticals Inc. | Jul 21, 2023 | 2 | -$185K | 4 | Jul 25, 2023 | Chief Commercial Officer |
| VRCA | Verrica Pharmaceuticals Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Commercial Officer |
| VRCA | Verrica Pharmaceuticals Inc. | Feb 24, 2022 | 1 | $0 | 4 | Feb 25, 2022 | Chief Commercial Officer |